Association of initial core volume on non-contrast CT using a deep learning algorithm with clinical outcomes in acute ischemic stroke: a potential tool for selection and prognosis?

BACKGROUND: In an extended time window, contrast-based neuroimaging is valuable for treatment selection or prognosis in patients with stroke undergoing reperfusion treatment. However, its immediate availability remains limited, especially in resource-constrained regions. We sought to evaluate the association of initial core volume (ICV) measured on non-contrast computed tomography (NCCT) by a deep learning-based algorithm with outcomes in patients undergoing reperfusion treatment. METHODS: Consecutive patients who received reperfusion treatments were collected from a prospectively maintained registry in three comprehensive stroke centers from January 2021 to May 2024. ICV on admission was estimated on NCCT by a previously validated deep learning algorithm (Methinks). Outcomes of interest included favorable outcome (modified Rankin Scale score 0-2 at 90 days) and symptomatic intracranial hemorrhage (sICH). RESULTS: The study comprised 658 patients of mean (SD) age 72.7 (14.4) years and median (IQR) baseline National Institutes of Health Stroke Scale (NIHSS) score of 12 (6-19). Primary endovascular treatment was performed in 53.7% of patients and 24.9% received IV thrombolysis only. Patients with favorable outcomes had a lower mean (SD) automated ICV (aICV; 12.9 (26.9) mL vs 34.9 (40) mL, P<0.001). Lower aICV was associated with a favorable outcome (adjusted OR 0.983 (95% CI 0.975 to 0.992), P<0.001) after adjusted logistic regression. For every 1 mL increase in aICV, the odds of a favorable outcome decreased by 1.7%. Patients who experienced sICH had a higher mean (SD) aICV (47.8 (61.1) mL vs 20.5 (32) mL, P=0.001). Higher aICV was independently associated with sICH (adjusted OR 1.014 (95% CI 1.004 to 1.025), P=0.009) after adjusted logistic regression. For every 1 mL increase in aICV, the odds of sICH increased by 1.4%. CONCLUSION: In patients with stroke undergoing reperfusion therapy, aICV assessment on NCCT predicts long-term outcomes and sICH. Further studies determining the potential role of aICV assessment to safely expand and simplify reperfusion therapies based on AI interpretation of NCCT may be justified.